Participants
acute suicidal behavior, head injury, Coma, sexual abuse, depression, substance abuse, brain dysfunction, traumatic, psychosis, PTSD, amnesia, mental disorder, ideations, intellectual disabilities, head trauma
EVENT, DISORDERS, COMA, BRAIN DYSFUNCTION
Participants are individuals between 12 and 18 years of age, meeting the criteria for PTSD (according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition), and victims of repeated sexual and/or physical abuse and/or domestic violence in childhood. Participants are recruited from different departments of Karakter, a large mental health organization for children and adolescents in the Netherlands. This applies the following inclusion criteria: (1) meeting the criteria for PTSD, assessed with the Clinical-Administered PTSD Scale for Children and Adolescents (CAPS-CA); (2) reporting a history of (repeated) physical and/or sexual abuse and/or domestic violence by a caretaker, family member, or person in authority; (3) the availability of a non-offending adult caregiver for the treatment, as the presence of a caregiver is part of the treatment design; (4) motivation and ability of the participant and the caregiver to attend weekly treatment sessions; (5) safe living circumstances to minimize the risk of retraumatization during the study; and (6) participants and caregivers have sufficient command of the Dutch language to participate in the treatment.Exclusion criteria are (1) acute suicidal behavior or suicidal ideations requiring immediate hospitalization; (2) severe head trauma indicated by a score < 9 on the Glasgow Coma Scale as known from the participant’s medical history, to avoid brain dysfunction or retrograde amnesia of the traumatic event due to head injury; (3) concurrent psychotherapy during the study; (4) current severe mental disorder in the participant’s main caregiver (as evaluated by the responsible clinician), such as psychosis, severe episode of depression, or severe substance abuse, to assure the ability of the caregiver to participate in the treatment; (5) a sibling of the participant already participating in the study (to avoid the transference of treatment effects if siblings are randomized in different conditions); and (6) intellectual disabilities (IQ < 70).